ID   P3C2B_HUMAN             Reviewed;        1634 AA.
AC   O00750; O95666; Q5SW99;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta;
DE            Short=PI3K-C2-beta;
DE            Short=PtdIns-3-kinase C2 subunit beta;
DE            EC=2.7.1.154;
DE   AltName: Full=C2-PI3K;
DE   AltName: Full=Phosphoinositide 3-kinase-C2-beta;
GN   Name=PIK3C2B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary gland;
RX   PubMed=9144573; DOI=10.1006/bbrc.1997.6495;
RA   Brown R.A., Ho L.K.F., Weber-Hall S.J., Shipley J.M., Fry M.J.;
RT   "Identification and cDNA cloning of a novel mammalian C2 domain-
RT   containing phosphoinositide 3-kinase, HsC2-PI3K.";
RL   Biochem. Biophys. Res. Commun. 233:537-544(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   TISSUE=Monocyte;
RX   PubMed=9830063; DOI=10.1074/jbc.273.49.33082;
RA   Arcaro A., Volinia S., Zvelebil M.J., Stein R.C., Watton S.J.,
RA   Layton M.J., Gout I., Ahmadi K., Downward J., Waterfield M.D.;
RT   "Human phosphoinositide 3-kinase C2beta, the role of calcium and the
RT   C2 domain in enzyme activity.";
RL   J. Biol. Chem. 273:33082-33090(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   IDENTIFICATION IN A COMPLEX WITH ERBB2 AND EGFR, INTERACTION WITH EGFR
RP   AND PDGFR, COFACTOR, AND FUNCTION.
RX   PubMed=10805725; DOI=10.1128/MCB.20.11.3817-3830.2000;
RA   Arcaro A., Zvelebil M.J., Wallasch C., Ullrich A., Waterfield M.D.,
RA   Domin J.;
RT   "Class II phosphoinositide 3-kinases are downstream targets of
RT   activated polypeptide growth factor receptors.";
RL   Mol. Cell. Biol. 20:3817-3830(2000).
RN   [5]
RP   IDENTIFICATION IN A COMPLEX WITH GRB2 AND EGFR, INTERACTION WITH SHC1
RP   AND GRB2, AND ENZYME REGULATION.
RX   PubMed=11533253; DOI=10.1128/MCB.21.19.6660-6667.2001;
RA   Wheeler M., Domin J.;
RT   "Recruitment of the class II phosphoinositide 3-kinase C2beta to the
RT   epidermal growth factor receptor: role of Grb2.";
RL   Mol. Cell. Biol. 21:6660-6667(2001).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=14563213; DOI=10.1186/1472-6890-3-4;
RA   El Sheikh S.S., Domin J., Tomtitchong P., Abel P., Stamp G.,
RA   Lalani E.-N.;
RT   "Topographical expression of class IA and class II phosphoinositide 3-
RT   kinase enzymes in normal human tissues is consistent with a role in
RT   differentiation.";
RL   BMC Clin. Pathol. 3:4-4(2003).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
CC   -!- FUNCTION: Phosphorylates PtdIns and PtdIns4P with a preference for
CC       PtdIns. Does not phosphorylate PtdIns(4,5)P2. May be involved in
CC       EGF and PDGF signaling cascades. {ECO:0000269|PubMed:10805725}.
CC   -!- CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4-
CC       phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:10805725};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10805725};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:10805725};
CC   -!- ENZYME REGULATION: Activated by GRB2.
CC       {ECO:0000269|PubMed:11533253}.
CC   -!- SUBUNIT: Part of a complex with ERBB2 and EGFR. Part of a complex
CC       with phosphorylated EGFR and GRB2. Interacts with phosphorylated
CC       EGFR and PDGFR, maybe indirectly. Interacts with GRB2 and SHC1.
CC       {ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11533253}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=9; IntAct=EBI-641107, EBI-297353;
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-641107, EBI-641062;
CC       P62993:GRB2; NbExp=2; IntAct=EBI-641107, EBI-401755;
CC       P16333:NCK1; NbExp=3; IntAct=EBI-641107, EBI-389883;
CC       P14373:TRIM27; NbExp=5; IntAct=EBI-641107, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Microsome {ECO:0000269|PubMed:14563213}.
CC       Cell membrane {ECO:0000269|PubMed:14563213}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:14563213}. Nucleus
CC       {ECO:0000269|PubMed:14563213}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:14563213}. Note=Found mostly in the microsome,
CC       but also in the plasma membrane and cytosol. Nuclear in testis.
CC   -!- TISSUE SPECIFICITY: Expressed in columnar and transitional
CC       epithelia, mononuclear cells, and ganglion cells (at protein
CC       level). Widely expressed, with highest levels in thymus and
CC       placenta and lowest in peripheral blood, skeletal muscle and
CC       kidney. {ECO:0000269|PubMed:14563213, ECO:0000269|PubMed:9144573}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00879, ECO:0000255|PROSITE-
CC       ProRule:PRU00880}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-26 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA74194.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y11312; CAA72168.1; -; mRNA.
DR   EMBL; Y13892; CAA74194.1; ALT_INIT; mRNA.
DR   EMBL; AL606489; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS1446.1; -.
DR   PIR; JC5500; JC5500.
DR   PIR; PC4346; PC4346.
DR   RefSeq; NP_002637.3; NM_002646.3.
DR   RefSeq; XP_005245314.1; XM_005245257.2.
DR   RefSeq; XP_011507932.1; XM_011509630.2.
DR   RefSeq; XP_011507933.1; XM_011509631.2.
DR   RefSeq; XP_016856962.1; XM_017001473.1.
DR   RefSeq; XP_016856963.1; XM_017001474.1.
DR   UniGene; Hs.497487; -.
DR   ProteinModelPortal; O00750; -.
DR   BioGrid; 111305; 16.
DR   IntAct; O00750; 11.
DR   MINT; MINT-2794980; -.
DR   STRING; 9606.ENSP00000356155; -.
DR   BindingDB; O00750; -.
DR   ChEMBL; CHEMBL5554; -.
DR   GuidetoPHARMACOLOGY; 2151; -.
DR   SwissLipids; SLP:000000893; -.
DR   iPTMnet; O00750; -.
DR   PhosphoSitePlus; O00750; -.
DR   BioMuta; PIK3C2B; -.
DR   EPD; O00750; -.
DR   MaxQB; O00750; -.
DR   PaxDb; O00750; -.
DR   PeptideAtlas; O00750; -.
DR   PRIDE; O00750; -.
DR   DNASU; 5287; -.
DR   Ensembl; ENST00000367187; ENSP00000356155; ENSG00000133056.
DR   GeneID; 5287; -.
DR   KEGG; hsa:5287; -.
DR   UCSC; uc001haw.4; human.
DR   CTD; 5287; -.
DR   DisGeNET; 5287; -.
DR   GeneCards; PIK3C2B; -.
DR   HGNC; HGNC:8972; PIK3C2B.
DR   HPA; HPA030515; -.
DR   HPA; HPA050360; -.
DR   MIM; 602838; gene.
DR   neXtProt; NX_O00750; -.
DR   OpenTargets; ENSG00000133056; -.
DR   PharmGKB; PA33305; -.
DR   eggNOG; KOG0905; Eukaryota.
DR   eggNOG; COG5032; LUCA.
DR   GeneTree; ENSGT00760000119110; -.
DR   HOVERGEN; HBG082099; -.
DR   InParanoid; O00750; -.
DR   KO; K00923; -.
DR   OMA; IHLQERP; -.
DR   OrthoDB; EOG091G00FC; -.
DR   PhylomeDB; O00750; -.
DR   TreeFam; TF102031; -.
DR   BioCyc; MetaCyc:HS05725-MONOMER; -.
DR   BRENDA; 2.7.1.137; 2681.
DR   BRENDA; 2.7.1.154; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   SignaLink; O00750; -.
DR   SIGNOR; O00750; -.
DR   ChiTaRS; PIK3C2B; human.
DR   GeneWiki; PIK3C2B; -.
DR   GenomeRNAi; 5287; -.
DR   PRO; PR:O00750; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000133056; -.
DR   CleanEx; HS_PIK3C2B; -.
DR   ExpressionAtlas; O00750; baseline and differential.
DR   Genevisible; O00750; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030139; C:endocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; IBA:GO_Central.
DR   GO; GO:0035005; F:1-phosphatidylinositol-4-phosphate 3-kinase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0001727; F:lipid kinase activity; IEA:Ensembl.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:1905037; P:autophagosome organization; IEA:Ensembl.
DR   GO; GO:0009267; P:cellular response to starvation; IEA:Ensembl.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IEA:InterPro.
DR   GO; GO:0043491; P:protein kinase B signaling; IEA:Ensembl.
DR   Gene3D; 1.10.1070.11; -; 1.
DR   Gene3D; 2.60.40.150; -; 2.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   InterPro; IPR018936; PI3/4_kinase_CS.
DR   InterPro; IPR002420; PI3K_C2_dom.
DR   InterPro; IPR000341; PI3K_Ras-bd_dom.
DR   InterPro; IPR015433; PI_Kinase.
DR   InterPro; IPR001263; PInositide-3_kin_accessory_dom.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   PANTHER; PTHR10048; PTHR10048; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   Pfam; PF00792; PI3K_C2; 1.
DR   Pfam; PF00794; PI3K_rbd; 1.
DR   Pfam; PF00613; PI3Ka; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00142; PI3K_C2; 1.
DR   SMART; SM00144; PI3K_rbd; 1.
DR   SMART; SM00145; PI3Ka; 1.
DR   SMART; SM00146; PI3Kc; 1.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   SUPFAM; SSF49562; SSF49562; 2.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00915; PI3_4_KINASE_1; 1.
DR   PROSITE; PS00916; PI3_4_KINASE_2; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
DR   PROSITE; PS51547; PI3K_C2; 1.
DR   PROSITE; PS51546; PI3K_RBD; 1.
DR   PROSITE; PS51545; PIK_HELICAL; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Kinase; Membrane; Microsome;
KW   Nucleotide-binding; Nucleus; Reference proteome; Transferase.
FT   CHAIN         1   1634       Phosphatidylinositol 4-phosphate 3-kinase
FT                                C2 domain-containing subunit beta.
FT                                /FTId=PRO_0000088798.
FT   DOMAIN      375    463       PI3K-RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00879}.
FT   DOMAIN      635    786       C2 PI3K-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041, ECO:0000255|PROSITE-
FT                                ProRule:PRU00880}.
FT   DOMAIN      805    981       PIK helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00878}.
FT   DOMAIN     1079   1343       PI3K/PI4K. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00269}.
FT   DOMAIN     1365   1481       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN     1517   1608       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   REGION        2    298       Interaction with GRB2.
FT                                {ECO:0000269|PubMed:11533253}.
FT   COMPBIAS    156    162       Pro-rich.
FT   COMPBIAS    169    174       Pro-rich.
FT   CONFLICT      6      6       G -> D (in Ref. 1; CAA72168).
FT                                {ECO:0000305}.
FT   CONFLICT     63     63       P -> S (in Ref. 2; CAA74194).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       R -> W (in Ref. 2; CAA74194).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       Q -> L (in Ref. 2; CAA74194).
FT                                {ECO:0000305}.
FT   CONFLICT    246    246       A -> V (in Ref. 1; CAA72168).
FT                                {ECO:0000305}.
FT   CONFLICT    278    278       K -> E (in Ref. 2; CAA74194).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       P -> S (in Ref. 2; CAA74194).
FT                                {ECO:0000305}.
FT   CONFLICT    664    665       EL -> DM (in Ref. 1; CAA72168).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1634 AA;  184768 MW;  CA817BA77C12E833 CRC64;
     MSSTQGNGEH WKSLESVGIS RKELAMAEAL QMEYDALSRL RHDKEENRAK QNADPSLISW
     DEPGVDFYSK PAGRRTDLKL LRGLSGSDPT LNYNSLSPQE GPPNHSTSQG PQPGSDPWPK
     GSLSGDYLYI FDGSDGGVSS SPGPGDIEGS CKKLSPPPLP PRASIWDTPP LPPRKGSPSS
     SKISQPSDIN TFSLVEQLPG KLLEHRILEE EEVLGGGGQG RLLGSVDYDG INDAITRLNL
     KSTYDAEMLR DATRGWKEGR GPLDFSKDTS GKPVARSKTM PPQVPPRTYA SRYGNRKNAT
     PGKNRRISAA PVGSRPHTVA NGHELFEVSE ERDEEVAAFC HMLDILRSGS DIQDYFLTGY
     VWSAVTPSPE HLGDEVNLKV TVLCDRLQEA LTFTCNCSST VDLLIYQTLC YTHDDLRNVD
     VGDFVLKPCG LEEFLQNKHA LGSHEYIQYC RKFDIDIRLQ LMEQKVVRSD LARTVNDDQS
     PSTLNYLVHL QERPVKQTIS RQALSLLFDT YHNEVDAFLL ADGDFPLKAD RVVQSVKAIC
     NALAAVETPE ITSALNQLPP CPSRMQPKIQ KDPSVLAVRE NREKVVEALT AAILDLVELY
     CNTFNADFQT AVPGSRKHDL VQEACHFARS LAFTVYATHR IPIIWATSYE DFYLSCSLSH
     GGKELCSPLQ TRRAHFSKYL FHLIVWDQQI CFPVQVNRLP RETLLCATLY ALPIPPPGSS
     SEANKQRRVP EALGWVTTPL FNFRQVLTCG RKLLGLWPAT QENPSARWSA PNFHQPDSVI
     LQIDFPTSAF DIKFTSPPGD KFSPRYEFGS LREEDQRKLK DIMQKESLYW LTDADKKRLW
     EKRYYCHSEV SSLPLVLASA PSWEWACLPD IYVLLKQWTH MNHQDALGLL HATFPDQEVR
     RMAVQWIGSL SDAELLDYLP QLVQALKYEC YLDSPLVRFL LKRAVSDLRV THYFFWLLKD
     GLKDSQFSIR YQYLLAALLC CCGKGLREEF NRQCWLVNAL AKLAQQVREA APSARQGILR
     TGLEEVKQFF ALNGSCRLPL SPSLLVKGIV PRDCSYFNSN AVPLKLSFQN VDPLGENIRV
     IFKCGDDLRQ DMLTLQMIRI MSKIWVQEGL DMRMVIFRCF STGRGRGMVE MIPNAETLRK
     IQVEHGVTGS FKDRPLADWL QKHNPGEDEY EKAVENFIYS CAGCCVATYV LGICDRHNDN
     IMLKTTGHMF HIDFGRFLGH AQMFGNIKRD RAPFVFTSDM AYVINGGDKP SSRFHDFVDL
     CCQAYNLIRK HTHLFLNLLG LMLSCGIPEL SDLEDLKYVY DALRPQDTEA NATTYFTRLI
     ESSLGSVATK LNFFIHNLAQ MKFTGSDDRL TLSFASRTHT LKSSGRISDV FLCRHEKIFH
     PNKGYIYVVK VMRENTHEAT YIQRTFEEFQ ELHNKLRLLF PSSHLPSFPS RFVIGRSRGE
     AVAERRREEL NGYIWHLIHA PPEVAECDLV YTFFHPLPRD EKAMGTSPAP KSSDGTWARP
     VGKVGGEVKL SISYKNNKLF IMVMHIRGLQ LLQDGNDPDP YVKIYLLPDP QKTTKRKTKV
     ARKTCNPTYN EMLVYDGIPK GDLQQRELQL SVLSEQGFWE NVLLGEVNIR LRELDLAQEK
     TGWFALGSRS HGTL
//
